Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions

NCT05439408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Biological Availability

Interventions

DRUG: Dasatinib ASD 100 mg
DRUG: Dasatinib 140 MG [Sprycel]

Sponsor

Xspray Pharma AB

Collaborators

[object Object]